Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Oxymetazoline + HPMC in Allergic Rhinitis
NCT01986582Phase 2Completed
- Sponsor
- American Lung Association
- Start
- Oct 2013
- Primary completion
- Feb 2014
- Modality
- Polymer-based Nanoparticles, Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of hypromellose in allergic rhinitis (AR), sponsored by American Lung Association. Started Oct 2013; status: completed.
02
Drugs
hypromellose
03
Conditions
allergic rhinitis (AR)
Beyond the preview
Go deeper on NCT01986582.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01986582.